Results 21 to 30 of about 127,738 (290)

The Impact of Carbohydrate Antigen 19-9 on Survival in Patients with Clinical Stage I and II Pancreatic Cancer. [PDF]

Ann Surg Oncol, 2022
Melucci AD, Chacon AC, Burchard PR, Tsagkalidis V, Casabianca AS, Goyal S, Switchenko JM, Kooby DA, Staley CA, Carpizo DR, Shah MM.   +10 more
europepmc   +3 more sources

Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuvant therapy in pancreatic cancer. [PDF]

Cancer
Martos MP, Dickey EM, Abdilleh K, Ahmad SA, Maithel SK, Leigh-Matijakovich N, Kim HJ, Abbott DE, Zafar SN, Kooby DA, Parikh AA, Hosein PJ, Merchant NB, Datta J, Hester CA.   +14 more
europepmc   +2 more sources

Thymolipoma with high production of carbohydrate antigen 19-9 [PDF]

The Journal of Thoracic and Cardiovascular Surgery, 2004
1. Oppenheimer BS, Oppenheimer ET, Stout AP, et al. The latent period in carcinogenesis by plastics in rats and its relation to the presarcomatous stage. Cancer. 1958;11:204. 2. Jennings TA, Peterson L, Axiotis CA. Angiosarcoma associated with foreign body material. Cancer. 1988;62:2436-44. 3. Ben-Izhak O, Vlodavsky E, Ofer A.
Maekawa, Shinichi, Okabayashi, Kan, Hiratsuka, Masafumi, Hamada, Masakatsu, Shirakusa, Takayuki   +4 more
openaire   +3 more sources

Preoperative Serum Carbohydrate Antigen 19-9 Levels Cannot Predict the Surgical Resectability of Pancreatic Cancer: A Meta-Analysis

Pathology and Oncology Research, 2022
Background and Aims: Pancreatic ductal adenocarcinoma has one of the worst prognosis of all malignancies. This investigated the relationship between the preoperative serum carbohydrate antigen 19-9 and surgical resectability.Methods: A systematic search ...
Márton Benke, Nelli Farkas, Nelli Farkas, Nelli Farkas, Péter Hegyi, Péter Hegyi, Péter Hegyi, Benedek Tinusz, Benedek Tinusz, Patrícia Sarlós, Patrícia Sarlós, Patrícia Sarlós, Bálint Erőss, Bálint Erőss, Kata Szemes, Nóra Vörhendi, Zsolt Szakács, Zsolt Szakács, Ákos Szücs, Ákos Szücs   +19 more
doaj   +1 more source

Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19–9 in periampullary cancer patients receiving pancreaticoduodenectomy

Asian Journal of Surgery, 2021
Background: We assessed the use of serum concentrations of carbohydrate antigen (CA) 19–9 and carcinoembryonic antigen (CEA) measured during the preoperative diagnostic workup as prognostic factors for survival in patients with periampullary carcinoma ...
Sang Hun Park, Jun Ho Shin, Kyung Uk Jung, Sung Ryol Lee   +3 more
doaj   +1 more source

Elevated Carbohydrate Antigen 19-9 (CA 19-9) in Patients with Echinococcus Infection [PDF]

Clinical Chemistry and Laboratory Medicine, 2001
The carbohydrate antigen 19-9 (CA 19-9), a determinant (sialylated lacto-N-fucopentaose 119) of a circulating oligosaccharide antigen, is a frequently used tumor marker. Echinococcus spp. infects humans throughout the world and may be able to synthesize closely related molecules which could interfere with the measurement and interpretation of CA 19-9 ...
Pfister M, Gottstein B, Kretschmer R, Cerny T, Cerny A   +4 more
openaire   +3 more sources

Tumor Marker in Early Detection of Malignancies in Type 2 Diabetes: A Case Series Analysis

International Journal of Diabetes and Technology, 2023
The association between type 2 diabetes mellitus (T2DM) and malignancy has gained significant attention, with a heightened susceptibility to specific cancers.
Jothydev Kesavadev, Arun Shankar, Ashwin David Ashok, P. G. Balagopal, Gopika Krishnan, Anjana Basanth   +5 more
doaj   +1 more source

Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer

Diseases, 2021
Colorectal cancer (CRC) is the third most common cancer worldwide. A diagnosis at early stages with enhanced screening methods is vital as metastases and recurrences increase mortality.
Leilani Lakemeyer, Silvia Sander, Mathias Wittau, Doris Henne-Bruns, Marko Kornmann, Johannes Lemke   +5 more
doaj   +1 more source

Proposed carbohydrate antigen 19-9 (CA19-9) cut-off values for the detection of pancreatic cancer in patients with poorly controlled diabetes: a real-world study

Endocrine Journal, 2023
CA19-9 is a tumor marker for pancreatic cancer (PC), and the nondiabetic cut-off level is 37 U/mL. CA19-9 levels are said to rise in patients with tumors like PC and intraductal papillary mucinous neoplasm (IPMN). CA19-9 levels have also been shown to be
Taku Yamada, Taichi Minami, Masayo Yamada, Yasuo Terauchi   +3 more
doaj   +1 more source

CA 19-9 in Ovarian Immature Teratoma- A Potential Tumour Marker or A Masquerade? [PDF]

Journal of Clinical and Diagnostic Research, 2022
Carbohydrate antigen 19-9, also known as Cancer Antigen (CA 19-9) is a tumour marker found elevated in certain ovarian tumours. Although, reports of its association with mature teratoma are considerable, little is mentioned about its association with ...
Julie H John, R Sanghamita, Ajay Halder, Sramana Mukhopadhyay, Shweta Patel   +4 more
doaj   +1 more source